Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

The Vertex Speed merges the worlds of mountain running and climbing. New for spring 2025, the shoe follows the Vertex Alpine, ...

Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...

A group of cystic fibrosis patients could be denied access to a cutting-edge therapy after manufacturer Vertex refused to submit data to cost-effectiveness body NICE. The manufacturer's decision ...

over the next six months as part of the company's transition towards becoming a developer of therapies that edit genes within the body. December 4, 2024 CMS enters agreement with Vertex ...